Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Supportive measures in aggressive cytostatic therapy].

C Urban, I Slavc, G Maurer

    Padiatrie Und Padologie
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Novel case of combination antibiotic therapy for treatment of a complicated polymicrobial urinary tract infection with one organism harboring a metallo-β-lactamase (MBL) in a pregnant patient.

    IDCases·2024
    Same author

    <i>Edwardsiella tarda</i>, a rare human pathogen isolated from a perihepatic abscess: Implications of transient versus long term colonization of the gastrointestinal tract.

    IDCases·2021
    Same author

    Novel double beta-lactam therapy for <i>Granulicatella adiacens</i> infective endocarditis.

    IDCases·2021
    Same author

    Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2019
    Same author

    Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.

    Pediatric blood & cancer·2018
    Same author

    False positive serum levels of (1-3)-ß-D-Glucan after infusion of intravenous immunoglobulins and time to normalisation.

    The Journal of infection·2017
    Same journal

    [Is the Supply of Medicines in Danger?]

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    See all related articles

    Central venous lines provide significant advantages for supportive care in children undergoing intensive chemotherapy. This method of venous access did not increase infectious complications, improving overall treatment support.

    Area of Science:

    • Pediatric Oncology
    • Hematology
    • Clinical Supportive Care

    Context:

    • Intensive chemotherapy regimens for childhood cancers have advanced treatment outcomes.
    • Increased chemotherapy intensity leads to significant treatment-related complications.
    • Effective supportive care is crucial for managing these complications.

    Purpose:

    • To evaluate the safety and efficacy of central venous lines for supportive care in pediatric cancer patients undergoing aggressive chemotherapy.
    • To assess the incidence of infectious complications associated with central venous line use in this population.

    Summary:

    • Central venous lines facilitate essential supportive measures including blood component therapy, infection prophylaxis, and parenteral nutrition.
    • The study observed that central venous lines did not result in a higher rate of infectious complications.

    Related Experiment Videos

  • Implementation of central venous lines demonstrated significant benefits in managing supportive care needs.

    • Impact:

    • Central venous lines are a safe and effective tool for enhancing supportive care in pediatric oncology.
    • Improved supportive care through central venous access can lead to better patient tolerance of intensive chemotherapy.
    • This approach supports the cornerstone of modern cancer therapy by optimizing patient management.